Cipla is recalling over 1,800 boxes of Lanthanum Carbonate chewable tablets in the US due to reports of broken tablets. The recall, classified as Class II, affects the medication used for high... Nov ...

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Cipla shares rose 2.78 per cent to hit a high of Rs 1,602.70 on BSE. The pharma stock is up 26 per cent year-to-date. An analyst at Ashika Stock Broking said that The share price of Cipla has ...

Cipla Ltd. promoters Samina Hamied and Rumana Hamied will exit the pharmaceutical company and offload stakes worth Rs 2,004 crore through a block deal on Monday. The equity shares will be sold at Rs 1 ...

Revenue 25,774.09 22,753.12 21,763.34 19,159.59 ...

Here’s how it works. Space can be a wondrous place, and we've got the pictures to prove it! Take a look at our favorite space pictures here, and if you're wondering what happened to today in ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Cipla's current price is Rs 1488.40, showing a decline of 0.29% today. The 7-day exponential moving average stands at Rs 1490.33. Cipla is currently trading at Rs 1486.05, reflecting a 0.45% decrease ...

Apart from the above, the company also develops medicines to treat a few other conditions. With a market capitalization exceeding Rs.517 billion (7.9 billion USD), Cipla is reported to be one of the ...